Phase 1 Trial Evaluating Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Patients With Advanced Cancer

NCT02136342 Phase 1 TERMINATED

The purpose of the study is to explore if chlorogenic acid is safe in patients with cancer.

Details

Lead sponsor	Chinese Academy of Medical Sciences
Phase	Phase 1
Status	TERMINATED
Start date	2014-05

Conditions

• Advanced Cancer

Interventions

• chlorogenic acid

Primary outcomes

• Number of adverse events — within the first 60 days after the first dose of chlorogenic acid